CEO and Director
Jacksonville Center for Clinical Research
Encore Research Group
Michael Koren, MD, is CEO and Director at the Jacksonville Center for Clinical Research (JCCR) of the Encore Research Group in Jacksonville, Florida. Dr. Koren directs activities at JCCR, a multispecialty research organization with eight locations that has conducted more than 1000 trials involving over 100 investigators. He also is a practicing cardiologist with the Apex Cardiovascular Group.
Dr. Koren is an honors graduate of Brandeis University and Harvard Medical School. During his medical school training, he completed additional course work at the Harvard School for Public Health and wrote an M.D. thesis involving computer decision analysis. More recently he was awarded a US patent for developing the software system Ask100Doctors. Dr. Koren received his postdoctoral training at New York Hospital/ Memorial Sloan-Kettering Cancer Center/ Cornell University Medical Center in internal medicine and cardiology. During his postdoctoral training, Dr. Koren served as a third-year chief resident, held a faculty position and published several papers and abstracts.
In recent years, Dr. Koren has served as the international lead principal investigator for several large multiple centered trials including ALLIANCE (a pivotal statin study), ROLE (ranolazine safety study), MENDEL (evolocumab) and OSLER (evolocumab). His scientific work, numbering over 100 abstracts and manuscripts, has been published in leading medical journals such as the Journal of the American College of Cardiology, Circulation, New England Journal of Medicine and The Lancet.
Dr. Koren has become interested in "the research of research." He has presented abstracts on this subject at national meetings and served as a Past President and Board Member for the Academy of Physicians in Clinical Research (APCR) and twice as co-chair of the Ponte Vedra Cardiovascular Symposium.